Study title:
AN 15447711 Medline 20070101.
TI Cyproheptadine's antiserotonin effects are responsible for its antimigraine activity.
SO Headache, {Headache}, Oct 2004, vol. 44, no. 9, p. 935, ISSN: 0017-8748. AU Lehrer-Joel-F. CM Comment on: Headache. 2004 Mar; 44(3):230-7. YR 2004.AN 15447711 Medline 20070101.
TI Cyproheptadine's antiserotonin effects are responsible for its antimigraine activity.
SO Headache, {Headache}, Oct 2004, vol. 44, no. 9, p. 935, ISSN: 0017-8748. AU Lehrer-Joel-F. CM Comment on: Headache. 2004 Mar; 44(3):230-7. YR 2004.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases [C10]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYPROHEPTADINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|